Evidence map›Paper›PMID 34110959›Full record

ReviewPharmaceutical biology2021

Possible therapeutic effects of

Mohammad Reza Khazdair, Shoukouh Ghafari, Mahmood Sadeghi

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Food science & nutrition · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Protective effects ofVeterinary research forum : an international quarterly journal · 2024
    Article
  14. Ayurvedic and Chinese Herbs against Coronaviruses.Current pharmaceutical design · 2024
    Review
  15. Current therapeutic research, clinical and experimental · 2024
    Article
  16. Potential Pharmacological Applications ofPlants (Basel, Switzerland) · 2023
    Review
  17. Review
  18. Review
  19. Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases.Evidence-based complementary and alternative medicine : eCAM · 2023
    Review
  20. The Potential of Vouacapanes fromAdvanced pharmaceutical bulletin · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad Reza KhazdairPharmaceutical Science and Clinical Physiology, Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.ORCID https://orcid.org/0000-0001-9854-6121
Shoukouh GhafariInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Mahmood SadeghiMedical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
Birjand University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCOVID-19 is a novel coronavirus that causes a severe infection in the respiratory system.

objectiveThe possible beneficial effects of

methodsThe key words including, COVID-19,

resultsThe current literature review showed that DISCUSSION AND

conclusionsThese preliminary data of molecular docking, animal, and clinical studies propose

Indexed as

COVID-19 Drug TreatmentNigella sativaAnimalsAnti-Inflammatory AgentsAntiviral AgentsBenzoquinonesCOVID-19CytokinesHumansImmune SystemInflammation MediatorsLungPlant ExtractsSARS-CoV-2Anti-Inflammatory AgentsAntiviral AgentsBenzoquinonesCytokinesInflammation MediatorsPlant Extractsthymoquinoneanti-inflammatoryantiviral effectsImmunomodulationmedicinal plant

Identifiers

PMID34110959
PMCPMC8204995
OpenAlexW3172463332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.